What challenges exist in the regulatory approval of cancer drugs?
The primary challenges in the regulatory approval of cancer drugs include the complexity of cancer itself, the need for personalized medicine, and the high cost of clinical trials. Additionally, the urgency to bring life-saving treatments to market must be balanced against the need for thorough testing to ensure patient safety.
